Conditional Myostatin Overexpression in Transgenic Mice
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current animal models are inadequate for studying myostatin activation and its effects on skeletal muscle, hindering the development of effective treatments for muscle size and strength-related conditions.
Innovation Solution
A conditional eukaryotic gene expression system involving separate regulatory and response constructs, specifically a muscle-specific promoter and a tetracycline-inducible reverse transactivation protein sequence, is used to create transgenic animals that allow for tissue-specific, conditional overexpression or inhibition of myostatin, enabling controlled manipulation of myostatin levels in skeletal muscle.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If myostatin is overexpressed in transgenic animals, then muscle mass decreases, but the ability to control timing and tissue-specificity of expression is lost
Solution Approach 1:
The transgene construct is divided into separate functional modules: a tissue-specific promoter element (e.g., muscle-specific) and a tetracycline-responsive element (TRE), which are separated in space and function. This segmentation allows independent control of tissue-specificity and inducibility, resolving the contradiction between achieving muscle mass effects and maintaining control versatility.
Solution Approach 2:
A tetracycline-responsive element (TRE) is introduced as an intermediary between the promoter and the myostatin coding sequence. This intermediary allows external control (via tetracycline/doxycycline administration) to regulate gene expression timing and level, enabling precise control over when and where muscle mass changes occur while maintaining the desired physiological effect.
2Adaptability or versatility
If myostatin expression is controlled using a tetracycline-responsive element, then expression timing can be regulated, but the system complexity increases
Solution Approach 1:
The tetracycline-responsive element (TRE) serves multiple functions simultaneously: it provides inducible expression control, maintains tissue-specificity when combined with muscle-specific promoters, and enables reversible regulation. This multi-functionality reduces the need for separate control mechanisms, thereby managing system complexity while achieving versatile expression regulation.
Solution Approach 2:
The system utilizes parameter changes in the form of tetracycline derivative concentration (doxycycline) to control expression levels. By varying this chemical parameter, researchers can precisely adjust myostatin expression timing and intensity without modifying the genetic construct itself, simplifying the operational complexity despite the sophisticated control capability.
3Reliability
If myostatin is overexpressed during embryonic development, then developmental abnormalities occur, but studying its role in adult muscle requires early expression
Solution Approach 1:
The transgenic construct is prepared in advance with all necessary control elements (tissue-specific promoter, TRE, myostatin coding sequence) integrated into a single functional unit. This preliminary construction of the inducible system allows the animals to develop normally during embryogenesis, and then enables immediate activation of myostatin overexpression at any desired postnatal time point, eliminating the need to wait for natural development to complete before studying adult muscle effects.
Data Source
AI summary
Provided herein are novel nucleic acid sequences, vectors comprising such nucleic acid sequences, host cells comprising such vectors, and transgenic animals comprising such nucleic acid sequences, and related molecules and methods relating thereto. Such novel nucleic acid sequences, vectors comprising such nucleic acid sequences, host cells comprising such vectors, and transgenic animals comprising such nucleic acid sequences, and related molecules and methods provide conditional overexpression of genes, such as myostatin, and transgenic animals conditionally overexpression genes, such as myostatin.